Clinical Trials on Primary Progressive Multiple Sclerosis in United Kingdom
Total 2265 results
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Wellspect HealthCareTerminatedMultiple Sclerosis | Bladder DysfunctionBelgium, Netherlands, Germany, United Kingdom
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
Grifols Therapeutics LLCCompletedMultiple Sclerosis, Relapsing-RemittingCanada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom
-
Queen Margaret UniversityNHS Lothian; Multiple Sclerosis Society UKCompletedMultiple Sclerosis | Foot DropUnited Kingdom
-
University of SheffieldSheffield Teaching Hospitals NHS Foundation Trust; Walton Centre NHS Foundation...CompletedDepression | Multiple SclerosisUnited Kingdom
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Terry L. WahlsActive, not recruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Poland, Romania, Russian Federation, South Africa, Ukraine, United Kingdom
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingRelapsing Remitting Multiple SclerosisChina, United States, Ukraine, Poland
-
University of OxfordMultiple Sclerosis Society of Great Britain and Northern IrelandCompletedMultiple Sclerosis | Optic NeuritisUnited Kingdom
-
University of EdinburghCompleted
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, United Kingdom, Austria, Italy
-
GlaxoSmithKlineCompletedMultiple Sclerosis, Relapsing-RemittingSpain, Bulgaria, Ukraine, United Kingdom, Sweden, Germany, Canada, Czech Republic
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
University of MiamiNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...Active, not recruitingAmyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Frontotemporal Dementia | Progressive Muscular Atrophy | ALS-Frontotemporal DementiaUnited States
-
University of Colorado, DenverCompleted
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | SpasticityUnited Kingdom
-
Institut fur Klinische Forschung, GermanyWeleda AGTerminated
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Massachusetts General HospitalCompletedLogopenic Variant Primary Progressive Aphasia | Non-Fluent Primary Progressive AphasiaUnited States
-
SanofiCompletedMultiple SclerosisUnited States, Canada, Germany, Italy, Spain, United Kingdom, Austria
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
EMD SeronoTerminatedRelapsing Multiple SclerosisUnited States, Sweden, Australia, Czech Republic, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Ukraine, Netherlands, Canada, France, Austria, Lebanon, Switzerland, Belgium
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
The Leeds Teaching Hospitals NHS TrustUnknownMultiple SclerosisUnited Kingdom
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
Sheikh Shakhbout Medical CityRecruitingSpasticity, Muscle | Sclerosis, Multiple | Spastic | MS (Multiple Sclerosis)United Arab Emirates
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Glasgow Caledonian UniversityCompleted
-
Immunic AGRecruitingMultiple Sclerosis, Relapsing-RemittingTurkey, United States, India, United Kingdom, Bosnia and Herzegovina, Estonia, Poland, Romania, Serbia, Ukraine, Armenia, Peru
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
The University of Texas Health Science Center,...CompletedMultiple Sclerosis (MS)United States
-
Marquette UniversityUniversity of Wisconsin, MilwaukeeCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Northwestern UniversityTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Massachusetts General HospitalNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingLogopenic Variant Primary Progressive Aphasia | Non-fluent Variant Primary Progressive Aphasia | Semantic Variant Primary Progressive AphasiaUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
Brigham and Women's HospitalNovartisRecruitingRelapsing Multiple SclerosisUnited States